FINAL PROGRAM 6TH EDITION - EuroMediCom

to be administered, they are less appealing than other Testosterone preparations. Further development of these pellets to decreaseinvasiveness of administration and increase patient acceptance may lead to their use for long term Testosterone replacement therapy.Their longevity and difficulty in removing them if serious adverse events occur, makes the implants and microcapsules less attractivefor elderly patients.Swiss Oats & Homeopathic Preparations:A recent trial demonstrated that this helped elevate free testosterone levels in those who were deficient and the vitamins, iron & otheringredients in this food supplement restored symptoms in andropausal men by releasing Testosterone bound to SHBG. Anothersupplement from the Tribulus family was shown laboratorily to raise serum DHEA which is a precursor of testosterone.SESSION 24AAANTI AGING WORKSHOP 9 STEM CELLS9.30 am / 9h30THE USE OF STEM CELL XENO-TRANSPLANTATION AS A TREATMENT OF AGING DISEASESLA TRANSPLANTATION DE CELLULES SOUCHES COMME TRAITEMENT DES MALADIES LIÉES À L’ÂGEMICHAEL E. MOLNAR(USA)CELLULES SOUCHESWorld believes dis-information by the media that stem cell transplantation was born in U.S.A. in 2001 and that only human embryonicstem cell transplantation is the acceptable way to carry out such treatment. Physicians have been victims of the same fiction spreadby peer-reviewed medical journals.In reality animal fetal precursor stem cell transplantation was first reported at the meeting of French Academy of Sciences by Brown-Seguard in 1889. Medical historians established 1931 as the year of birth of the new medical field of cell transplantation in Switzerland.To-date 99.7% of over 5 million patients treated by stem cell transplantation in the world have been treated by animal fetal precursorstem cell transplantation without a single fatality.This treatment is safer than taking a small dose of aspirin providing stem cell transplants are prepared in accordance with regulationof U.S. FDA 'PHS Guidelines on Infectious Disease Issues in Xenotransplantation' of January 19, 2001 (Federal Register, Volume 66,Number 19, pages 8120 - 1) by a lege artis method such as that of Bio-Cellular Research Organization LLC. This method incorporatesprimary organ culture and assures that there is no need for immunosuppression following SCT treatment.In 1956 cell xeno-transplantation was crushed in U.S., and since that time there are no German medical textbooks or journals dealingwith cell xeno-transplantation available at any U.S. medical school library.In 1997 cell xeno-transplantation was nearly quashed in Germany (with a reversal in 2000 by German Supreme Court).All regulations about cell xeno-transplantation disappeared in Switzerland, country of birth for this therapy.Since SCT has always focused on treatment of incurable or no longer treatable diseases there have not been any grounds to considerSCT a dangerous competition to the existing dominance of health care by the pharmaceutical industry.Claims that only human embryonic stem cell transplantation is 'the stem cell transplantation' have been contrary to all scientific factsto-date since such therapy has been recognized for 75+ years by all cell xeno-transplantation experts as oncogenic and thus neverused in clinical practice.Animal fetal precursor stem cell transplantation has been used in clinical practice in many countries: start in Switzerland, followed byGermany, France, Italy, Spain, Netherlands, Argentina, Mexico, Costa Rica, U.S.A (until 1956), U.S.S.R., Canada, Malaysia, Thailand,Hong Kong, Indonesia No ethical problems were ever encountered and reported anywhere.The described confusion, and repeated moves to destroy such a valuable therapy, deserves clarification.This paper is an attempt to do that.ANTI-AGING MEDICINESESSION 25AAANTI AGING WORKSHOP 10 PRACTICAL SESSION ON HOW TO IMPROVE THE DIGESTIVE SYSTEM11.00 am / 11h00INTESTINAL MUCOUS MEMBRANELA MUQUEUSE INTESTINALEINTESTINAL MICROFLORALA MICROFLORE INTESTINALEMICHAEL CULP(UK)FRANCISCO GUARNER(SPAIN)SÉANCE PRATIQUE SUR L'AMÉLIORATION DU SYSTÈME DIGESTIFCHAIR: GEORGES MOUTONMARCEL ROBERFROID (BELGIUM)124The human gut is the natural habitat for a large, diverse and dynamic population of micro-organisms which over millennia have adaptedto live on the mucosal surfaces or in the lumen. The interaction between gut bacteria and their host is a symbiotic relationship mutuallybeneficial for both partners. The host provides a nutrient-rich habitat and the bacteria confer important benefits to the host. Functionsof the microbiota include nutrition (fermentation of nondigestible substrates that results in production of short chain fatty acids,absorption of ions, production of aminoacids and vitamins), protection (the barrier effect that prevents invasion by alien microbes), andimportant trophic effects on the intestinal epithelium and the immune system (development and homeostasis of local and systemicimmunity).Symbiosis between host and gut bacteria can be optimized by prebiotics. Inulin-type fructans have been shown to improve the